Well, good news for me, anyway.
As many of you know, there's been an explosion in recent years of what are called CAR-T treatments for blood cancers in general and for multiple myeloma in particular. Unlike ordinary chemo treatments, CAR-T involves taking T cells from a patient (e.g., me) and shipping them off to a lab where they undergo genetic magic and are then infused back into the patient. It's a one-time treatment and shows considerable promise as an almost complete cure.¹
There are a bunch of CAR-T treatments being developed, but the one I've been following most closely has been a Chinese version licensed in the US by Johnson & Johnson. Today, it received its final FDA clearance:
The Food and Drug Administration on Monday cleared the therapy, named Carvykti, for the treatment of multiple myeloma in adult patients whose disease has worsened despite prior treatments with other drugs.
....In one of J&J’s U.S. studies, about 98% of the 97 multiple-myeloma patients treated with Carvykti had a significant reduction in the proteins that signal the presence of myeloma, and 83% had a complete remission, indicating no detectable cancer cells, at a median of 22 months after treatment.
Joseph Mikhael, chief medical officer of the International Myeloma Foundation, said the effectiveness demonstrated in the study was “really unprecedented. That’s why there’s so much excitement around it.”
This is obviously good news for me, but it's not unalloyed. First of all, CAR-T treatments have potentially serious side effects, though they're short-term and mostly seem to be quite controllable these days. Second, CAR-T treatments are typically given to patients who are at the end of their rope, which doesn't describe me. However, even with some risk involved, I'd rather try this while I'm still relatively healthy since I suspect the treatment is more effective the healthier you are. Third, CAR-T therapies cost about half a million bucks.
All that said, I'm going to push my oncologist to see what it takes for me to qualify for this. I don't expect anything immediate, but it would be nice to get approved for this within the next year or so.
¹In the blood cancer world, terminology is confusing. "Complete remission" doesn't actually mean complete remission. It means "cancer levels are so low they're undetectable." That's pretty good! But there are still a few cancerous cells roaming around that will probably make a comeback eventually.